MedTrace Logo

Studying Health Outcomes After Treatment in Patients With Retinoblastoma

NCT03932786 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2025-09-19

No results posted yet for this study

Summary

This trial studies health outcomes after treatment in patients with retinoblastoma. Gathering health information over time from patients and family members through vision assessments, samples of tissue and saliva, and questionnaires may help doctors learn more about what causes retinoblastoma, identify long-term health outcomes for patients with retinoblastoma, and find out which therapies may be the best for treating retinoblastoma

Conditions

  • Retinoblastoma
  • Cancer Survivor
  • Biological Sibling
  • Intraocular Retinoblastoma
  • Unilateral Retinoblastoma

Interventions

PROCEDURE

Biospecimen collection

Collection of tissue and saliva samples

OTHER

Vision assessment

Undergo vision assessment

OTHER

Questionnaire administration

Complete questionnaires

OTHER

Quality of life assessment

Complete questionnaires

OTHER

Laboratory Biomarker Analysis

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt-Ingram Cancer Center

    lead OTHER

Principal Investigators

  • Debra Friedman, MD · Vanderbilt Medical Center

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-24
Primary Completion
2030-01-31
Completion
2031-01-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03932786 on ClinicalTrials.gov